Choolip & Sciences츌립앤사이언스
291650 · KOSDAQ · ₩291650 · 츌립앤사이언스
₩2,310▼ ₩75 (3.14%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 48.4% | 48.2% | 71.3% | 78.6% | 80.0% | 58.1% |
| Operating margin | −159.1% | −222.6% | −651.2% | −5,019.5% | −2,322.3% | −1,510.4% |
| Net margin | −215.8% | −246.0% | −803.7% | −5,593.0% | −1,986.2% | −1,422.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +54.0% | +223.7% | +345.3% | −32.1% | +33.0% | — |
| Operating income growth | −10.1% | −10.6% | +42.2% | −46.7% | −104.6% | — |
| Net income growth | −35.1% | +0.9% | +36.0% | −91.2% | −85.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −33.1% | −32.1% | −42.5% | −60.9% | −23.5% | −12.2% |
| Return on assets | −21.3% | −23.6% | −27.0% | −34.8% | −18.0% | −11.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 62.2% | 45.6% | 25.7% | 110.2% | 56.2% | 5.7% |
| Net debt to equity | −9.4% | −49.7% | −61.6% | −100.2% | 19.2% | — |
| Current ratio | 127.4% | 219.7% | 483.6% | 164.3% | 1,496.0% | 5,748.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Choolip & Sciences / 츌립앤사이언스 / 291650 / KRX:291650
Source: KRX statistical information